Arbutus Biopharma Corp
ABUS
Market Cap$666.51M
Close$
$-0.41
111.8% downside
Current Fair Value
111.8% downsideOvervalued by 111.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $666.51 Million |
|---|---|
| Enterprise Value | $637.39 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.38 |
| Beta | 1.24 |
| Outstanding Shares | 190,707,085 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.67 |
|---|---|
| PEG | -23.29 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 99.54 |
| Enterprise Value to EBIT | -7.99 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Arbutus Biopharma Corp
CEO: William Collier